Today

Agents

Chat

Arena

Discover

More

App

Apimeds Pharmaceuticals names Christopher Kim chief scientific officer - APUS News | Rallies

Apimeds Pharmaceuticals names Christopher Kim chief scientific officer

APUS•2026-08-06

Christopher Kim appointed chief scientific officer

Apimeds Pharmaceuticals US appointed Christopher Kim as chief scientific officer, effective Aug. 5, 2026.
Kim will lead scientific, clinical and regulatory development for the APITOX program, targeting approvals and commercialization.
He has been closely associated with APITOX for many years, with scientific, technical and regulatory expertise tied to the program.

Related News

Dropbox Q2 2026 results reflect core execution gains in conversion, retention, pricing, company says

DBX•2026-08-06

Zurn Elkay CAO Mark W. Peterson sells 25,000 shares for $1.33 million

ZWS•2026-08-06

Paymentus director Gary Trainor disposes of 79,999 common shares worth $3.26 million

Sources

S

Apimeds Pharmaceuticals names Christopher Kim chief scientific officer

Sec

PAY

•

2026-08-06

LTC Properties signs equity distribution agreement for issuer share forward sales

LTC•2026-08-06

LeMaitre Vascular to join Needham Virtual MedTech & Diagnostics 1x1 Conference

LMAT•2026-08-06